Editas Medicine (NQ: EDIT )
5.460
-0.080
(-1.44%)
Streaming Delayed Price
Updated: 11:03 AM EDT, Jul 15, 2024
Add to My Watchlist
Headline News about Editas Medicine
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Analyst Expectations for Editas Medicine's Future
August 29, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/744604/doctor-and-patient-in-a-hospital-room.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Expert Ratings for Editas Medicine
August 03, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/737749/3-worried-investors-talk-at-a-table.jpg)
![](https://g.foolcdn.com/editorial/images/737122/patient-sitting-on-hospital-bed.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://g.foolcdn.com/editorial/images/736667/concerned-investor-with-two-people-in-background.jpg)
![](/next-assets/images/schema-image-default.png)
What 6 Analyst Ratings Have To Say About Editas Medicine
June 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
6 Analysts Have This to Say About Editas Medicine
May 08, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Editas Medicine: Q1 Earnings Insights
May 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/15/john_wiley__sons_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/736168/parabola.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/15/gambling.com_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Preview: Editas Medicine's Earnings
May 04, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/727423/physician-shaking-patients-hand.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_12358.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/06/09/edit.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/12/gene-editing.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/06/01/screenshot_2023-06-01_at_5.40.36_pm.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/07/short-squeeze-stocks.jpg)
![](https://g.foolcdn.com/editorial/images/733047/scientists-examine-cell-make-up-microscope-biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/15/oneok_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1403.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/02/crispr-genetic-editing.jpg)
![](https://g.foolcdn.com/editorial/images/728529/scientists-examine-cell-make-up-microscope-biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/17/satsuma_pharmaceuticals_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_c_1600.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.